Reuters logo
in 4 months
BRIEF-Biophytis secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT
April 4, 2017 / 5:35 AM / in 4 months

BRIEF-Biophytis secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT

1 Min Read

April 4 (Reuters) - Biophytis SA:

* Secures funding for phase 2B clinical trial in Sarcopenia, SARA-INT

* Capital increase subscribed by several private of 3.7 million euros completed by issuing 1,310,431 new shares at a price of 2.85 euros per share

* Arranges a bond financing of 15 million euros ($16.00 million) Source text: bit.ly/2nVJzbk Further company coverage: ($1 = 0.9375 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below